Regulatory News
Tuesday, April 12, 2016
UPDATE 2-Lawsuit vs Pfizer over Celebrex, Bextra safety is revived
April 12 (Reuters) - A federal appeals court on Tuesday
revived a long-running class-action lawsuit accusing Pfizer Inc
of causing tens of billions of dollars of losses for
shareholders by...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment